InSilico Medicine Concludes Series E Funding Round, Securing Approximately US$123 Million
2 week ago / Read about 0 minute
Author:小编   

InSilico Medicine has successfully completed its Series E funding round, raising a total of approximately US$123 million. These funds will be strategically allocated towards enhancing the company's AI platform and bolstering its innovative drug research and development pipeline.